Ribozyme Enters Diagnostics Arena Through Fujirebio Deal
Ribozyme entered into an agreement with Fujirebio Inc. to develop and commercialize ribozyme-based clinical diagnostic products, marking the first significant union between Ribozyme and its allosteric ribozyme platform technology with a diagnostics company.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST